Ravi Kant

1.5k total citations
103 papers, 1.2k citations indexed

About

Ravi Kant is a scholar working on Organic Chemistry, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Ravi Kant has authored 103 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Organic Chemistry, 31 papers in Materials Chemistry and 20 papers in Molecular Biology. Recurrent topics in Ravi Kant's work include Synthesis and biological activity (14 papers), ZnO doping and properties (11 papers) and Click Chemistry and Applications (9 papers). Ravi Kant is often cited by papers focused on Synthesis and biological activity (14 papers), ZnO doping and properties (11 papers) and Click Chemistry and Applications (9 papers). Ravi Kant collaborates with scholars based in India, United States and United Kingdom. Ravi Kant's co-authors include O.P. Pandey, K. Singh, Brian Bothner, Syed Ishraque Ahmad, Sudhir G. Warkar, Manish Jain, Rajesh K. Singh, Vamseedhar Rayaprolu, Adam Zlotnick and Joseph Che‐Yen Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Ravi Kant

96 papers receiving 1.1k citations

Peers

Ravi Kant
Dali Liu United States
Mary Cano‐Sarabia Spain
Takeshi Higuchi Japan
Mohit Chawla Saudi Arabia
Jiahua Wang China
Xiaoman Liu China
Pooja Tiwari United States
Atsushi Izumi Japan
Camilla A. Santos Brazil
Michael Kaszuba United Kingdom
Dali Liu United States
Ravi Kant
Citations per year, relative to Ravi Kant Ravi Kant (= 1×) peers Dali Liu

Countries citing papers authored by Ravi Kant

Since Specialization
Citations

This map shows the geographic impact of Ravi Kant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Kant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Kant more than expected).

Fields of papers citing papers by Ravi Kant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Kant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Kant. The network helps show where Ravi Kant may publish in the future.

Co-authorship network of co-authors of Ravi Kant

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Kant. A scholar is included among the top collaborators of Ravi Kant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Kant. Ravi Kant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Hamda, Anukriti Singh, Shivam Pandey, et al.. (2025). Recent Advancements in Breast Cancer Therapies and Biomarkers: Mechanisms and Clinical Significance. Current Pharmaceutical Biotechnology. 26(15). 2381–2402. 2 indexed citations
2.
Grzesiowski, Paweł, et al.. (2025). Mpox unveiled: Global epidemiology, treatment advances, and prevention strategies. One Health. 20. 101030–101030. 3 indexed citations
3.
4.
Pinheiro, Francisca, et al.. (2025). Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations. Proceedings of the National Academy of Sciences. 123(1). e2519908122–e2519908122.
5.
Kant, Ravi, Camila S. Freitas, James C. K. Ng, et al.. (2024). Antimicrobial activity of compounds identified by artificial intelligence discovery engine targeting enzymes involved in Neisseria gonorrhoeae peptidoglycan metabolism. Biological Research. 57(1). 62–62. 6 indexed citations
6.
Kant, Ravi & K. K. Sharma. (2023). Hybrid material of α-Fe2O3 nanostructure with reduced graphene oxide: Enhanced dielectric and optical properties in relation to their composition and morphology. Journal of Molecular Structure. 1282. 135216–135216. 6 indexed citations
7.
Kant, Ravi, et al.. (2023). Synthetic Analogues of Gibbilimbol B Induce Bioenergetic Damage and Calcium Imbalance in Trypanosoma cruzi. Life. 13(3). 663–663. 1 indexed citations
8.
9.
10.
Kant, Ravi, et al.. (2023). Antibody Binding Captures High Energy State of an Antigen: The Case of Nsp1 SARS-CoV-2 as Revealed by Hydrogen–Deuterium Exchange Mass Spectrometry. International Journal of Molecular Sciences. 24(24). 17342–17342. 2 indexed citations
11.
Jha, Prakash, et al.. (2023). Bactericidal activity of esculetin is associated with impaired cell wall synthesis by targeting glutamate racemase of Neisseria gonorrhoeae. Molecular Diversity. 28(5). 3181–3198. 2 indexed citations
12.
Kant, Ravi, Prakash Jha, Daman Saluja, & Madhu Chopra. (2022). Identification of novel inhibitors of Neisseria gonorrhoeae MurI using homology modeling, structure-based pharmacophore, molecular docking, and molecular dynamics simulation-based approach. Journal of Biomolecular Structure and Dynamics. 41(15). 7433–7446. 7 indexed citations
13.
Shukla, Rishi Kumar & Ravi Kant. (2020). Assessment of phytochemical screening by Fourier Transform Infrared spectroscopic analysis of peach (Prunus persica) seed biomass from Uttarakhand region of India. Journal of Applied and Natural Science. 12(4). 519–524. 7 indexed citations
14.
Singh, Rajesh K., et al.. (2016). Synthesis of novel Imidazo [1,2-b] pyridazine derivatives and study of their biomedicinal efficacy. Chemical Biology Letters. 3(2). 38–43. 4 indexed citations
15.
Singh, Rajesh Kumar, et al.. (2016). Discovery of novel pyrazoles as potent antimicrobial and antimalarial agents. Der pharmacia lettre. 8(6). 182–187. 1 indexed citations
16.
Kant, Ravi, et al.. (2013). Synthesis, characterization and biological activity of some molybdenum(VI) complexes. Der pharma chemica. 5(4). 347–356. 3 indexed citations
17.
Pareek, P. K., et al.. (2011). Synthesis and biological evaluation of 4-thiazolidinone derivatives incorporating benzothiazole moiety. 2(1). 7 indexed citations
18.
Pareek, P. K., et al.. (2010). Synthesis of some biologically active benzothiazole derivatives. Der pharma chemica. 2(5). 281–293. 7 indexed citations
19.
Pareek, P. K., et al.. (2010). Synthesis of some biologically important 2-thiobarbituric acidderivatives incorporating benzothiazole moiety. Der pharmacia lettre. 2(4). 274–283. 8 indexed citations
20.
Kant, Ravi, et al.. (2010). Synthesis and spectral characterization of some bromo-benzothiazolo pyrazolines. 2(1). 25–27. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dali Liu Breakdown of academic impact, for papers by Mary Cano‐Sarabia Breakdown of academic impact, for papers by Takeshi Higuchi Breakdown of academic impact, for papers by Mohit Chawla Breakdown of academic impact, for papers by Jiahua Wang Breakdown of academic impact, for papers by Xiaoman Liu Breakdown of academic impact, for papers by Pooja Tiwari Breakdown of academic impact, for papers by Atsushi Izumi Breakdown of academic impact, for papers by Camilla A. Santos Breakdown of academic impact, for papers by Michael Kaszuba
Rankless by CCL
2026